STOCK TITAN

Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
earnings date

Madrigal Pharmaceuticals (Nasdaq: MDGL) will release first-quarter 2026 financial results on Wednesday, May 6, 2026, prior to the U.S. market open. Management will host a live webcast at 8:00 a.m. Eastern Time to review financial and operating results, accessible via the company Investor Relations website.

The live webcast is recommended to be accessed by registering at least 15 minutes early and will be available on-demand about two hours after the live event.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • None.

Negative

  • None.

News Market Reaction – MDGL

+0.81%
1 alert
+0.81% News Effect

On the day this news was published, MDGL gained 0.81%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings release date: May 6, 2026 Webcast time: 8:00 a.m. Eastern Time Registration lead time: 15 minutes +1 more
4 metrics
Earnings release date May 6, 2026 First-quarter 2026 financial results release before U.S. market open
Webcast time 8:00 a.m. Eastern Time Management webcast to review Q1 2026 results
Registration lead time 15 minutes Recommended minimum time before webcast start to register
Webcast replay delay 2 hours Time after live webcast when replay becomes available

Market Reality Check

Price: $497.27 Vol: Volume 209,071 is below t...
low vol
$497.27 Last Close
Volume Volume 209,071 is below the 20-day average of 376,768 ahead of the earnings date. low
Technical Shares at 527.69 are trading above the 200-day MA of 460.88 and below the 52-week high of 615.

Peers on Argus

MDGL is modestly higher (0.11%) on an earnings-date notice while close peers sho...

MDGL is modestly higher (0.11%) on an earnings-date notice while close peers show mixed, mostly small moves, and no names are in the momentum scanner, indicating a stock-specific posture.

Previous Earnings date Reports

1 past event · Latest: Feb 02 (Neutral)
Same Type Pattern 1 events
Date Event Sentiment Move Catalyst
Feb 02 Earnings date announcement Neutral +0.1% Set Q4 and full-year 2025 results date and webcast details.
Pattern Detected

Prior earnings-date scheduling news produced a very small price move, suggesting these notices have been low-volatility catalysts.

Recent Company History

This announcement schedules Madrigal’s first‑quarter 2026 results and webcast, similar to its prior notice on Feb. 2, 2026 for fourth‑quarter and full‑year 2025 results. That earlier earnings‑date press release led to a modest 0.09% move. Around that period, Madrigal reported substantial 2025 net sales and cash, and continued to issue employee inducement equity awards and participate in healthcare conferences, signaling steady operational and investor‑relations communication.

Historical Comparison

+0.1% avg move · Past earnings-date news for MDGL led to a muted 0.09% move, so this new scheduling update closely mi...
earnings date
+0.1%
Average Historical Move earnings date

Past earnings-date news for MDGL led to a muted 0.09% move, so this new scheduling update closely mirrors prior low-volatility reactions.

Madrigal maintains a consistent pattern of pre-announcing earnings dates and hosting morning webcasts for financial updates.

Market Pulse Summary

This announcement sets the date and time for Madrigal’s first‑quarter 2026 results and webcast, cont...
Analysis

This announcement sets the date and time for Madrigal’s first‑quarter 2026 results and webcast, continuing its practice of early earnings scheduling. Investors can monitor this event alongside the company’s prior full‑year 2025 results and recent operational updates to gauge continuity in sales, cash position, and strategic progress. Attention will likely center on how Q1 performance compares to the strong 2025 baseline already disclosed.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CONSHOHOCKEN, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its first-quarter 2026 financial results on Wednesday, May 6, 2026, prior to the open of the U.S. financial markets.

Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.

The webcast will be available approximately two hours after the live webcast.

About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit www.madrigalpharma.com.

Investor Contact
Tina Ventura, Madrigal Pharmaceuticals, Inc., IR@madrigalpharma.com

Media Contact
Christopher Frates, Madrigal Pharmaceuticals, Inc., media@madrigalpharma.com


FAQ

When will Madrigal Pharmaceuticals (MDGL) release Q1 2026 results and hold the webcast?

Madrigal will release Q1 2026 results on May 6, 2026, before market open, with a live webcast at 8:00 a.m. ET. According to the company, management will review financial and operating results during the webcast and the replay will be available about two hours later.

How can investors access the MDGL May 6, 2026 webcast for first-quarter 2026 results?

Investors can access the webcast via the Investor Relations section of Madrigal's website and should register in advance. According to the company, participants are recommended to register at least 15 minutes before the 8:00 a.m. ET start to ensure a timely connection.

Will Madrigal (MDGL) provide an on-demand replay of the May 6, 2026 webcast and when?

Yes. The webcast replay will be available approximately two hours after the live event on the company's Investor Relations site. According to the company, the on-demand version allows investors who miss the live 8:00 a.m. ET presentation to review the results later the same day.

What should shareholders do to prepare for Madrigal's (MDGL) Q1 2026 webcast on May 6, 2026?

Shareholders should register on the Investor Relations webcast page and join at least 15 minutes before 8:00 a.m. ET to secure connection. According to the company, early registration helps avoid delays and ensures access to the live review of financial and operating results.